Connection

Anna Ridolfo to Anti-Retroviral Agents

Back to Details
This is a "connection" page, showing publications Anna Ridolfo has written about Anti-Retroviral Agents.
Anna Ridolfo
Connection Strength
0.682
Anti-Retroviral Agents
  1. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older. J Acquir Immune Defic Syndr. 2018 06 01; 78(2):193-201.
    View in: PubMed
    Score: 0.389
  2. Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy. BMC Infect Dis. 2018 Nov 12; 18(1):556.
    View in: PubMed
    Score: 0.100
  3. How relevant are the drug-drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life? J Antimicrob Chemother. 2018 08 01; 73(8):2271-2273.
    View in: PubMed
    Score: 0.098
  4. Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study. Antivir Ther. 2018; 23(5):405-413.
    View in: PubMed
    Score: 0.094
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.